The present invention pertains generally to systems and methods for reshaping and structurally altering the cornea of an eye to improve the vision of a patient. More particularly, the present invention pertains to systems and methods that combine intrastromal laser treatment with conventional vision correction to improve the vision of a patient. The present invention is particularly, but not exclusively, useful as a system and method for reshaping the cornea of an eye, wherein an intrastromal laser corrects the depth-of-field of the eye, and wherein a conventional vision correction is used to compensate for any pre-op or post-op aberrations.
Recently, laser surgical procedures have become a common way to treat various diseases of the eye. Presbyopia is one such disease. A patient suffering from presbyopia has a diminished ability to focus on near objects because of a decreased accommodation of the lens of the eye. Simple solutions, such as over-the-counter reading glasses, may help a patient overcome some of the symptoms associated with presbyopia. But, in many cases, a laser procedure that alters the cornea, thus increasing depth-of-field of the eye, is a more appropriate treatment option for presbyopia. In addition, a patient with presbyopia may also be near-sighted or far-sighted. Thus, a laser treatment used to treat presbyopia, or any other health condition associated with the eye, may also need to account for more than one disorder of the eye to yield the best possible results for an individual patient.
In many laser procedures, it is desirable to modify the optical performance of the cornea. The cornea of an eye has five (5) different identifiable layers of tissue. Proceeding in a posterior direction from the anterior surface of the cornea, these layers are: the epithelium; Bowman's capsule (membrane); the stroma; Descemet's membrane; and the endothelium. Behind the cornea is an aqueous-containing space called the anterior chamber. Importantly, the anterior chamber exerts pressure on the cornea to cause bio-mechanical consequences. Specifically, the anterior chamber of the eye exerts an intraocular pressure against the cornea. This creates stresses and strains that place the cornea under tension.
A typical cornea has a thickness of approximately 500 μm. From a bio-mechanical perspective, Bowman's capsule and the stroma are the most important layers of the cornea. Within the cornea, Bowman's capsule is a relatively thin layer (approximately 10 μm) that is located below the epithelium, within the anterior one hundred microns of the cornea. The stroma then comprises almost all of the remaining four hundred microns in the cornea. Further, the tissue of Bowman's capsule creates a relatively strong, elastic membrane that effectively resists forces in tension. On the other hand, the stroma comprises relatively weak connective tissue.
Bio-mechanically, Bowman's capsule and the stroma are both significantly influenced by the intraocular pressure that is exerted against the cornea by the anterior chamber. In particular, this pressure is transferred from the anterior chamber, and through the stroma, to Bowman's membrane. It is known that how these forces are transmitted through the stroma will affect the shape of the cornea. Thus, by disrupting forces between interconnective tissue in the stroma, the overall force distribution in the cornea can be altered. Consequently, this altered force distribution will then act against Bowman's capsule. In response, the shape of Bowman's capsule is changed, and due to the elasticity and strength of Bowman's capsule, this change will directly influence the shape of the cornea. With this in mind, and as intended for the present invention, refractive surgery is accomplished by making cuts on predetermined surfaces in the stroma to induce a redistribution of bio-mechanical forces that will reshape the cornea.
In view of the complexity of the cornea's internal structure and its related biomechanical properties, it is not surprising that surgical procedures alone may not resolve every optical aberration. In addition, surgical procedures may correct one eye problem while causing post-op optical aberrations that were not present before surgery. However, with the knowledge of the stromal tissue's biomechanical properties, the behavior of the stromal tissue in response to a laser procedure may be predicted. Thus, additional corrective measures may be developed based on the predicted behavior of the stromal tissue. One type of corrective measure that can be employed is a conventional correction means, such as spectacles or contact lenses. Spectacles or contact lenses can be selected or manufactured to compensate for pre-op or post-op corneal aberrations based on the needs of the patient.
In light of the above, it is an object of the present invention to provide a system and method for correcting a vision deficiency related to the depth-of-field of an eye. Another object of the present invention is to provide a two-step ophthalmic method for correcting a vision deficiency that combines a laser procedure with conventional vision correction. Yet another object of the present invention is to provide a vision correction method that is easy to use, is relatively simple to manufacture, and is relatively cost effective.
In accordance with the present invention, a system for reshaping the cornea of an eye of a patient in order to increase the depth-of-field of the eye is used in a two-stage process. First, the depth-of-field is corrected with an intrastromal laser treatment. Preferably, this is done as disclosed in U.S. application Ser. No. 11/958,202, filed on Dec. 17, 2007, for an invention entitled “Method for Intrastromal Refractive Surgery” which is assigned to the same assignee as the present invention. Second, after the laser treatment has been completed, conventional vision correction is provided by spectacles or contact lenses. This conventional correction will then compensate for remaining pre-op aberrations, as well as residual aberrations in the patient's post-op vision (e.g. spherical, cylindrical, or sphero-cylindrical aberrations) that may have been induced during the laser treatment. As envisioned for the present invention, a manufacture of the conventional vision correction means for post-op vision will depend on preview testing that is conducted before the laser treatment is performed. As a consequence, the purpose of the present invention is to increase a patient's depth-of-field (i.e. laser treatment), correct for remaining pre-op aberrations, and compensate for induced aberrations (i.e. conventional vision correction means). Note: depending on the patient's tolerance for the laser treatment, there may be no induced aberrations to compensate for. If so, only pre-op aberrations need to be corrected by the conventional vision correction means.
Structurally, the system incorporates a diagnostic unit that includes a computer. One use of this diagnostic unit is for measuring a refractive error of the eye. Specifically, this is done to obtain a pre-op prescription for the eye that will correct the refractive error. Then, based on the measured refractive error and other properties of the eye, the laser treatment that will be used to increase the depth-of-field of the eye is planned. As implied above, a laser unit is provided in the system for use in performing the laser treatment. Preferably, this laser unit is a so-called femtosecond laser, but it can also be a picosecond or a nanosecond laser. Also, the computer is preferably programmed to take diagnostic data, such as the refractive error and other properties of the eye, as input, and to predict an induced refractive shift that will likely result from the laser treatment.
Based on the pre-op prescription and the predicted refractive shift, a preview lens is selected or manufactured for the system of the present invention. This preview lens can then be used to conduct a preview test on the eye of the patient. In particular, the purpose of this preview test is to determine the patient's toleration of the laser treatment. Specifically, the determination is made whether the post-op vision of the patient will tolerate a combination of the pre-op prescription and the predicted refractive shift.
An important aspect of the present invention is the use of a conventional vision correction means, after the laser treatment has been completed. In accordance with the present invention, this conventional vision correction means may be either spectacles or contact lenses but can also be intraocular lenses or other means of vision correction. In either case, the lenses are selected or manufactured according to the toleration of the patient, as determined in the preview test. For instance, when the preview test indicates the patient is intolerant, the vision correction lens is selected or manufactured to correct both the pre-op prescription and the refractive shift. On the other hand, when the preview test indicates patient toleration, the vision correction lens is made to correct only the pre-op prescription. It may happen, however, that after the laser treatment a patient may be emmetropic. If so, no further vision correction need be provided.
For the methods of the present invention, the first step involves measuring a refractive error for the eye of the patient. As mentioned above, this is done to obtain a pre-op prescription for correcting the refractive error. Next, a laser treatment is planned that will increase the depth-of-field of the eye. As part of this planning, a computer is programmed to calculate an induced refractive shift (for most patients, this is an unwanted side effect) that will likely result from the laser treatment that causes the induced refractive shift. After the pre-op prescription and the induced refractive shift have been identified, they are combined to create a preview plan that will be used for manufacturing the preview lens.
As noted above, the preview lens is selected or manufactured to evaluate the patient's tolerance for a predicted post-op vision. Once the patient's toleration has been established, the laser treatment to increase the depth-of-field of the eye is performed. After the laser treatment has been performed, it is then determined whether conventional correction means need to be employed to achieve good vision quality and comfort for the patient.
Based on the preview test, there are essentially three different conclusions for the method(s) of the present invention. First, when the patient is intolerant of the post-op vision, as determined in the preview test, a conventional correction means is provided that includes both the pre-op prescription and a correction for the refractive shift. Second, when the patient is tolerant of the post-op vision, as determined in the preview test, a conventional correction means is provided for correction of the pre-op prescription only. And, third, when a patient is emmetropic, no further action is required and no conventional correction means need be provided.
Referring initially to
Still referring to
Now referring to
Still referring to
While the particular Method for Complementing Conventional Vision Correction with Laser Correction of the Cornea as herein shown and disclosed in detail is fully capable of obtaining the objects and providing the advantages herein before stated, it is to be understood that it is merely illustrative of the presently preferred embodiments of the invention and that no limitations are intended to the details of construction or design herein shown other than as described in the appended claims.
The application claims the benefit of U.S. Provisional Patent Application Ser. No. 61/285,373, filed Dec. 10, 2009.
Number | Date | Country | |
---|---|---|---|
61285373 | Dec 2009 | US |